Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 11217 - 11224 of 12008 results
Healthcare Mergers and Acquisitions - Pitfalls and Emerging Issues
December 18, 2012| Blog| Viewpoint
Nickelodeon Target of Privacy Complaint; Final COPPA Amendments to be Released Tomorrow
December 18, 2012| Blog| Viewpoint
New York Law Journal: Smart Devices in the Workplace
December 18, 2012| Blog| Viewpoint
New Municipal-Owned Solar Farm in Massachusetts, but More Obstacles Ahead
December 17, 2012| Blog| Viewpoint
HHS Issues Comprehensive "Essential Health Benefits" Proposed Regulations
December 14, 2012| Blog| Viewpoint
Defense Agencies Seek Electrical Power from Biomass
December 13, 2012| Blog| Viewpoint
Detroit's "Fiscal Cliff" and Michigan's Response
December 13, 2012| Blog| Viewpoint
OIG Approves Pharmacy’s Provision of Free or Below Market Value Items in Limited Circumstances
December 12, 2012| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|